Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis.

Vargas DA, Prieto MD, Martínez-Valencia AJ, Cossio A, Burgess KEV, Burchmore RJS, Gómez MA.

Front Pharmacol. 2019 Jun 20;10:657. doi: 10.3389/fphar.2019.00657. eCollection 2019.

2.

Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018.

Lew FH, McQuown B, Borrego J, Cunningham S, Burgess KE.

Vet Comp Oncol. 2019 May 9. doi: 10.1111/vco.12491. [Epub ahead of print]

PMID:
31069932
3.

Substantial Extracellular Metabolic Differences Found Between Phylogenetically Closely Related Probiotic and Pathogenic Strains of Escherichia coli.

van der Hooft JJJ, Goldstone RJ, Harris S, Burgess KEV, Smith DGE.

Front Microbiol. 2019 Feb 19;10:252. doi: 10.3389/fmicb.2019.00252. eCollection 2019.

4.

Unexpected differential metabolic responses of Campylobacter jejuni to the abundant presence of glutamate and fucose.

van der Hooft JJJ, Alghefari W, Watson E, Everest P, Morton FR, Burgess KEV, Smith DGE.

Metabolomics. 2018 Oct 23;14(11):144. doi: 10.1007/s11306-018-1438-5.

5.

Urologic Oncology.

Burgess KE, DeRegis CJ.

Vet Clin North Am Small Anim Pract. 2019 Mar;49(2):311-323. doi: 10.1016/j.cvsm.2018.11.006. Epub 2019 Jan 8. Review.

PMID:
30635132
6.

Intestinal lymphoma in dogs: 84 cases (1997-2012).

Sogame N, Risbon R, Burgess KE.

J Am Vet Med Assoc. 2018 Feb 15;252(4):440-447. doi: 10.2460/javma.252.4.440.

PMID:
29393741
7.

Preliminary investigation of blood concentrations of insulin-like growth factor, insulin, lactate and β-hydroxybutyrate in dogs with lymphoma as compared with matched controls.

McQuown B, Burgess KE, Heinze CR.

Vet Comp Oncol. 2018 Jun;16(2):262-267. doi: 10.1111/vco.12376. Epub 2017 Dec 4.

PMID:
29205754
8.

MetaNetter 2: A Cytoscape plugin for ab initio network analysis and metabolite feature classification.

Burgess KEV, Borutzki Y, Rankin N, Daly R, Jourdan F.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Dec 15;1071:68-74. doi: 10.1016/j.jchromb.2017.08.015. Epub 2017 Sep 23.

9.

Rabacfosadine for relapsed canine B-cell lymphoma: Efficacy and adverse event profiles of 2 different doses.

Saba CF, Vickery KR, Clifford CA, Burgess KE, Phillips B, Vail DM, Wright ZM, Morges MA, Fan TM, Thamm DH.

Vet Comp Oncol. 2018 Mar;16(1):E76-E82. doi: 10.1111/vco.12337. Epub 2017 Sep 11.

PMID:
28891260
10.

Improving cartilage phenotype from differentiated pericytes in tunable peptide hydrogels.

Alakpa EV, Jayawarna V, Burgess KEV, West CC, Péault B, Ulijn RV, Dalby MJ.

Sci Rep. 2017 Jul 31;7(1):6895. doi: 10.1038/s41598-017-07255-z.

11.

Nacre Topography Produces Higher Crystallinity in Bone than Chemically Induced Osteogenesis.

Alakpa EV, Burgess KEV, Chung P, Riehle MO, Gadegaard N, Dalby MJ, Cusack M.

ACS Nano. 2017 Jul 25;11(7):6717-6727. doi: 10.1021/acsnano.7b01044. Epub 2017 Jul 5.

12.

Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana.

Mwenechanya R, Kovářová J, Dickens NJ, Mudaliar M, Herzyk P, Vincent IM, Weidt SK, Burgess KE, Burchmore RJS, Pountain AW, Smith TK, Creek DJ, Kim DH, Lepesheva GI, Barrett MP.

PLoS Negl Trop Dis. 2017 Jun 16;11(6):e0005649. doi: 10.1371/journal.pntd.0005649. eCollection 2017 Jun.

13.

Unsupervised Discovery and Comparison of Structural Families Across Multiple Samples in Untargeted Metabolomics.

van der Hooft JJJ, Wandy J, Young F, Padmanabhan S, Gerasimidis K, Burgess KEV, Barrett MP, Rogers S.

Anal Chem. 2017 Jul 18;89(14):7569-7577. doi: 10.1021/acs.analchem.7b01391. Epub 2017 Jul 5.

14.

Candida albicans Mycofilms Support Staphylococcus aureus Colonization and Enhances Miconazole Resistance in Dual-Species Interactions.

Kean R, Rajendran R, Haggarty J, Townsend EM, Short B, Burgess KE, Lang S, Millington O, Mackay WG, Williams C, Ramage G.

Front Microbiol. 2017 Feb 23;8:258. doi: 10.3389/fmicb.2017.00258. eCollection 2017.

15.

A novel targeted/untargeted GC-Orbitrap metabolomics methodology applied to Candida albicans and Staphylococcus aureus biofilms.

Weidt S, Haggarty J, Kean R, Cojocariu CI, Silcock PJ, Rajendran R, Ramage G, Burgess KE.

Metabolomics. 2016;12(12):189. doi: 10.1007/s11306-016-1134-2. Epub 2016 Nov 5.

16.

Topic modeling for untargeted substructure exploration in metabolomics.

van der Hooft JJ, Wandy J, Barrett MP, Burgess KE, Rogers S.

Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):13738-13743. Epub 2016 Nov 16.

17.

Utility of Computed Tomography versus Abdominal Ultrasound Examination to Identify Iliosacral Lymphadenomegaly in Dogs with Apocrine Gland Adenocarcinoma of the Anal Sac.

Palladino S, Keyerleber MA, King RG, Burgess KE.

J Vet Intern Med. 2016 Nov;30(6):1858-1863. doi: 10.1111/jvim.14601. Epub 2016 Oct 24.

18.

Recent advances in liquid and gas chromatography methodology for extending coverage of the metabolome.

Haggarty J, Burgess KE.

Curr Opin Biotechnol. 2017 Feb;43:77-85. doi: 10.1016/j.copbio.2016.09.006. Epub 2016 Oct 20. Review.

19.

Urinary antihypertensive drug metabolite screening using molecular networking coupled to high-resolution mass spectrometry fragmentation.

van der Hooft JJ, Padmanabhan S, Burgess KE, Barrett MP.

Metabolomics. 2016;12:125. Epub 2016 Jul 5.

20.

A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013).

Rau SE, Burgess KE.

Vet Comp Oncol. 2017 Sep;15(3):1019-1028. doi: 10.1111/vco.12243. Epub 2016 Jun 9.

PMID:
27277825
21.

Histologic and immunohistochemical characterization of thymic epithelial tumours in the dog.

Burgess KE, DeRegis CJ, Brown FS, Keating JH.

Vet Comp Oncol. 2016 Jun;14(2):113-21. doi: 10.1111/vco.12072. Epub 2013 Nov 7.

PMID:
27144380
22.

Glycolysis and pyrimidine biosynthesis are required for replication of adherent-invasive Escherichia coli in macrophages.

Thompson AP, O'Neill I, Smith EJ, Catchpole J, Fagan A, Burgess KE, Carmody RJ, Clarke DJ.

Microbiology. 2016 Jun;162(6):954-65. doi: 10.1099/mic.0.000289. Epub 2016 Apr 6.

PMID:
27058922
23.

A novel metabolomic approach used for the comparison of Staphylococcus aureus planktonic cells and biofilm samples.

Stipetic LH, Dalby MJ, Davies RL, Morton FR, Ramage G, Burgess KE.

Metabolomics. 2016;12:75. Epub 2016 Mar 8.

24.

Treatment of advanced canine anal sac adenocarcinoma with hypofractionated radiation therapy: 77 cases (1999-2013).

McQuown B, Keyerleber MA, Rosen K, McEntee MC, Burgess KE.

Vet Comp Oncol. 2017 Sep;15(3):840-851. doi: 10.1111/vco.12226. Epub 2016 Mar 16.

PMID:
26991552
25.

LC-MS-based absolute metabolite quantification: application to metabolic flux measurement in trypanosomes.

Kim DH, Achcar F, Breitling R, Burgess KE, Barrett MP.

Metabolomics. 2015;11(6):1721-1732. Epub 2015 Jul 9.

26.

Serially coupling hydrophobic interaction and reversed-phase chromatography with simultaneous gradients provides greater coverage of the metabolome.

Haggarty J, Oppermann M, Dalby MJ, Burchmore RJ, Cook K, Weidt S, Burgess KE.

Metabolomics. 2015;11(5):1465-1470. Epub 2015 Jan 11.

27.

Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).

Wendelburg KM, Price LL, Burgess KE, Lyons JA, Lew FH, Berg J.

J Am Vet Med Assoc. 2015 Aug 15;247(4):393-403. doi: 10.2460/javma.247.4.393.

PMID:
26225611
28.

Draft Genome Sequence of Isolate Staphylococcus aureus LHSKBClinical, Isolated from an Infected Hip.

Stipetic LH, Hamilton G, Dalby MJ, Davies RL, Meek RM, Ramage G, Smith DG, Burgess KE.

Genome Announc. 2015 Apr 30;3(2). pii: e00336-15. doi: 10.1128/genomeA.00336-15.

29.

Enhanced acylcarnitine annotation in high-resolution mass spectrometry data: fragmentation analysis for the classification and annotation of acylcarnitines.

van der Hooft JJ, Ridder L, Barrett MP, Burgess KE.

Front Bioeng Biotechnol. 2015 Mar 9;3:26. doi: 10.3389/fbioe.2015.00026. eCollection 2015.

30.

Probing the metabolic network in bloodstream-form Trypanosoma brucei using untargeted metabolomics with stable isotope labelled glucose.

Creek DJ, Mazet M, Achcar F, Anderson J, Kim DH, Kamour R, Morand P, Millerioux Y, Biran M, Kerkhoven EJ, Chokkathukalam A, Weidt SK, Burgess KE, Breitling R, Watson DG, Bringaud F, Barrett MP.

PLoS Pathog. 2015 Mar 16;11(3):e1004689. doi: 10.1371/journal.ppat.1004689. eCollection 2015 Mar.

31.

Potent trypanocidal curcumin analogs bearing a monoenone linker motif act on trypanosoma brucei by forming an adduct with trypanothione.

Alkhaldi AA, Creek DJ, Ibrahim H, Kim DH, Quashie NB, Burgess KE, Changtam C, Barrett MP, Suksamrarn A, de Koning HP.

Mol Pharmacol. 2015;87(3):451-64. doi: 10.1124/mol.114.096016. Epub 2014 Dec 19.

PMID:
25527638
32.

Doxorubicin chemotherapy for presumptive cardiac hemangiosarcoma in dogs.

Mullin CM, Arkans MA, Sammarco CD, Vail DM, Britton BM, Vickery KR, Risbon RE, Lachowicz J, Burgess KE, Manley CA, Clifford CA.

Vet Comp Oncol. 2016 Dec;14(4):e171-e183. doi: 10.1111/vco.12131. Epub 2014 Dec 18.

PMID:
25524594
33.

The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective.

Rankin NJ, Preiss D, Welsh P, Burgess KE, Nelson SM, Lawlor DA, Sattar N.

Atherosclerosis. 2014 Nov;237(1):287-300. doi: 10.1016/j.atherosclerosis.2014.09.024. Epub 2014 Sep 30. Review.

34.

Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma.

Morges MA, Burton JH, Saba CF, Vail DM, Burgess KE, Thamm DH.

J Vet Intern Med. 2014 Sep-Oct;28(5):1569-74. doi: 10.1111/jvim.12429.

35.
36.

MetAssign: probabilistic annotation of metabolites from LC-MS data using a Bayesian clustering approach.

Daly R, Rogers S, Wandy J, Jankevics A, Burgess KE, Breitling R.

Bioinformatics. 2014 Oct;30(19):2764-71. doi: 10.1093/bioinformatics/btu370. Epub 2014 Jun 9.

37.

Cutaneous lymphoma of the tarsus in cats: 23 cases (2000-2012).

Burr HD, Keating JH, Clifford CA, Burgess KE.

J Am Vet Med Assoc. 2014 Jun 15;244(12):1429-34. doi: 10.2460/javma.244.12.1429.

PMID:
24871066
38.

Influence of exercise intensity on training-induced tendon mechanical properties changes in older individuals.

Grosset JF, Breen L, Stewart CE, Burgess KE, Onambélé GL.

Age (Dordr). 2014 Jun;36(3):9657. doi: 10.1007/s11357-014-9657-9. Epub 2014 Apr 24.

39.

The emerging role of genomics in the diagnosis and workup of congenital urinary tract defects: a novel deletion syndrome on chromosome 3q13.31-22.1.

Materna-Kiryluk A, Kiryluk K, Burgess KE, Bieleninik A, Sanna-Cherchi S, Gharavi AG, Latos-Bielenska A.

Pediatr Nephrol. 2014 Feb;29(2):257-67. doi: 10.1007/s00467-013-2625-2. Epub 2013 Nov 30.

40.

Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.

Kahn SA, Mullin CM, de Lorimier LP, Burgess KE, Risbon RE, Fred RM 3rd, Drobatz K, Clifford CA.

Can Vet J. 2013 Mar;54(3):237-42.

41.

Mast cell tumor invading the cornea in a horse.

Halse S, Pizzirani S, Parry NM, Burgess KE.

Vet Ophthalmol. 2014 May;17(3):221-7. doi: 10.1111/vop.12084. Epub 2013 Aug 1.

PMID:
23905672
42.

Mutations in DSTYK and dominant urinary tract malformations.

Sanna-Cherchi S, Sampogna RV, Papeta N, Burgess KE, Nees SN, Perry BJ, Choi M, Bodria M, Liu Y, Weng PL, Lozanovski VJ, Verbitsky M, Lugani F, Sterken R, Paragas N, Caridi G, Carrea A, Dagnino M, Materna-Kiryluk A, Santamaria G, Murtas C, Ristoska-Bojkovska N, Izzi C, Kacak N, Bianco B, Giberti S, Gigante M, Piaggio G, Gesualdo L, Vukic DK, Vukojevic K, Saraga-Babic M, Saraga M, Gucev Z, Allegri L, Latos-Bielenska A, Casu D, State M, Scolari F, Ravazzolo R, Kiryluk K, Al-Awqati Q, D'Agati VD, Drummond IA, Tasic V, Lifton RP, Ghiggeri GM, Gharavi AG.

N Engl J Med. 2013 Aug 15;369(7):621-9. doi: 10.1056/NEJMoa1214479. Epub 2013 Jul 17.

43.

Copy-number disorders are a common cause of congenital kidney malformations.

Sanna-Cherchi S, Kiryluk K, Burgess KE, Bodria M, Sampson MG, Hadley D, Nees SN, Verbitsky M, Perry BJ, Sterken R, Lozanovski VJ, Materna-Kiryluk A, Barlassina C, Kini A, Corbani V, Carrea A, Somenzi D, Murtas C, Ristoska-Bojkovska N, Izzi C, Bianco B, Zaniew M, Flogelova H, Weng PL, Kacak N, Giberti S, Gigante M, Arapovic A, Drnasin K, Caridi G, Curioni S, Allegri F, Ammenti A, Ferretti S, Goj V, Bernardo L, Jobanputra V, Chung WK, Lifton RP, Sanders S, State M, Clark LN, Saraga M, Padmanabhan S, Dominiczak AF, Foroud T, Gesualdo L, Gucev Z, Allegri L, Latos-Bielenska A, Cusi D, Scolari F, Tasic V, Hakonarson H, Ghiggeri GM, Gharavi AG.

Am J Hum Genet. 2012 Dec 7;91(6):987-97. doi: 10.1016/j.ajhg.2012.10.007. Epub 2012 Nov 15.

44.

Molecular profiling reveals prognostically significant subtypes of canine lymphoma.

Frantz AM, Sarver AL, Ito D, Phang TL, Karimpour-Fard A, Scott MC, Valli VE, Lindblad-Toh K, Burgess KE, Husbands BD, Henson MS, Borgatti A, Kisseberth WC, Hunter LE, Breen M, O'Brien TD, Modiano JF.

Vet Pathol. 2013 Jul;50(4):693-703. doi: 10.1177/0300985812465325. Epub 2012 Nov 2.

45.

Do Fitflops increase lower limb muscle activity?

Burgess KE, Swinton PA.

Clin Biomech (Bristol, Avon). 2012 Dec;27(10):1078-82. doi: 10.1016/j.clinbiomech.2012.08.011. Epub 2012 Sep 25.

PMID:
23017840
46.

Stable isotope-assisted metabolomics for network-wide metabolic pathway elucidation.

Creek DJ, Chokkathukalam A, Jankevics A, Burgess KE, Breitling R, Barrett MP.

Anal Chem. 2012 Oct 16;84(20):8442-7. doi: 10.1021/ac3018795. Epub 2012 Sep 25.

47.

Metabolomics: a valuable tool for stem cell monitoring in regenerative medicine.

McNamara LE, Sjöström T, Meek RM, Oreffo RO, Su B, Dalby MJ, Burgess KE.

J R Soc Interface. 2012 Aug 7;9(73):1713-24. doi: 10.1098/rsif.2012.0169. Epub 2012 May 23. Review.

48.

Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosis.

Lockman KA, Baren JP, Pemberton CJ, Baghdadi H, Burgess KE, Plevris-Papaioannou N, Lee P, Howie F, Beckett G, Pryde A, Jaap AJ, Hayes PC, Filippi C, Plevris JN.

Liver Int. 2012 Aug;32(7):1079-92. doi: 10.1111/j.1478-3231.2012.02775.x. Epub 2012 Mar 19.

PMID:
22429485
49.

IDEOM: an Excel interface for analysis of LC-MS-based metabolomics data.

Creek DJ, Jankevics A, Burgess KE, Breitling R, Barrett MP.

Bioinformatics. 2012 Apr 1;28(7):1048-9. doi: 10.1093/bioinformatics/bts069. Epub 2012 Feb 4.

PMID:
22308147
50.

Angiofibroma of the nasal cavity in 13 dogs.

Burgess KE, Green EM, Wood RD, Dubielzig RR.

Vet Comp Oncol. 2011 Dec;9(4):304-9. doi: 10.1111/j.1476-5829.2011.00278.x. Epub 2011 Jul 26.

PMID:
22077412

Supplemental Content

Loading ...
Support Center